Literature DB >> 15609401

Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells.

Li-Duan Zheng1, Qiang-Song Tong, Liang Wang, Jun Liu, Wei Qian.   

Abstract

AIM: To explore the feasibility of enhancing apoptosis-inducing effects of chemotherapeutic drugs on human gastric cancer cells by stable transfection of extrinsic Smac gene.
METHODS: After Smac gene was transferred into gastric cancer cell line MKN-45, subclone cells were obtained by persistent G418 selection. Cellular Smac gene expression was determined by RT-PCR and Western blotting. After treatment with mitomycin (MMC) as an apoptotic inducer, in vitro cell growth activities were investigated by trypan blue-staining method and MTT colorimetry. Cell apoptosis and its rates were determined by electronic microscopy, annexin V-FITC and propidium iodide staining flow cytometry. Cellular caspase-3 protein expression and its activities were assayed by Western blotting and colorimetry.
RESULTS: When compared with MKN-45 cells, the selected subclone cell line MKN-45/Smac had significantly higher Smac mRNA (3.12+/-0.21 vs 0.82+/-0.14, t = 7.52, P<0.01) and protein levels (4.02+/-0.24 vs 0.98+/-0.11, t = 8.32, P<0.01). After treatment with 10 microg/mL MMC for 6-24 h, growth inhibition rate of MKN-45/Smac (15.8+/-1.2-54.8+/-2.9%) was significantly higher than that of MKN-45 (5.8+/-0.4- 24.0+/-1.5%, t = 6.42, P<0.01). Partial MKN-45/Smac cancer cells presented characteristic morphological changes of apoptosis under the electronic microscope with an apoptosis rate of 36.4+/-2.1%, which was significantly higher than that of MKN-45 (15.2+/-0.8%, t = 9.25, P<0.01). Compared with MKN-45, caspase-3 expression levels in MKN-45/Smac were improved significantly (3.39+/-0.42 vs 0.96+/-0.14, t = 8.63, P<0.01), while its activities were 3.25 times as many as those of MKN-45 (0.364+/-0.010 vs 0.112+/-0.007, t = 6.34, P<0.01).
CONCLUSION: Stable transfection of extrinsic Smac gene and its over-expression in gastric cancer cell line can significantly enhance cellular caspase-3 expression and activities, ameliorate apoptosis-inducing effects of mitomycin C on cancer cells, which is a novel strategy to improve chemotherapeutic effects on gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15609401      PMCID: PMC4205389          DOI: 10.3748/wjg.v11.i1.79

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  Mitochondria and apoptosis: new therapeutic targets.

Authors:  David M Hockenbery; Christopher D Giedt; Jason W O'Neill; Michael K Manion; Deborah E Banker
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

2.  c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosis.

Authors:  Susan A Vaziri; Dale R Grabowski; Masahiro Tabata; Katherine A Holmes; Joseph Sterk; Nagio Takigawa; Ronald M Bukowski; Mahrukh K Ganapathi; Ram Ganapathi
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

Review 3.  The role of chemotherapy in the current treatment of gastric cancer.

Authors:  Eric Van Cutsem; Daniel Haller; Atsushi Ohtsu
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

Review 4.  Inhibitors of apoptosis proteins in injury and disease.

Authors:  George Lotocki; Robert W Keane
Journal:  IUBMB Life       Date:  2002-11       Impact factor: 3.885

Review 5.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

Review 6.  Apoptosis in cancer--implications for therapy.

Authors:  Henning Schulze-Bergkamen; Peter H Krammer
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929

7.  Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway.

Authors:  I A McNeish; S Bell; T McKay; T Tenev; M Marani; N R Lemoine
Journal:  Exp Cell Res       Date:  2003-06-10       Impact factor: 3.905

Review 8.  Why target apoptosis in cancer treatment?

Authors:  Shailaja Kasibhatla; Ben Tseng
Journal:  Mol Cancer Ther       Date:  2003-06       Impact factor: 6.261

Review 9.  Apoptosis as a novel target for cancer chemoprevention.

Authors:  Shi-Yong Sun; Numsen Hail; Reuben Lotan
Journal:  J Natl Cancer Inst       Date:  2004-05-05       Impact factor: 13.506

10.  Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer.

Authors:  Stuart G Marcus; Daniel Cohen; Ke Lin; Kwok Wong; Scott Thompson; Adina Rothberger; Milan Potmesil; Spiros Hiotis; Elliot Newman
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  2 in total

1.  Effect of Smac on TRAIL-induced apoptosis of prostate cancer cell line PC-3 and the molecular mechanism.

Authors:  Miao Wang; Tao Huang; Fuqing Zeng; Guosong Jiang; Liang Wang; Liduan Zheng; Qiangsong Tong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

2.  Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression.

Authors:  Michiko Shintani; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Oncol Lett       Date:  2014-10-09       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.